12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
Posts Tagged ‘NASDAQ:VKTX’
Viking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial Results
Viking Therapeutics jumped by 9.74 percent on Tuesday to close at $30.19 apiece as investors repositioned portfolios ahead of the expected release of the results of its own weight...
Viking Therapeutics (VKTX) Rises on Expected Developments
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms.
Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?
We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc.
Jim Cramer Nailed These 11 Stock Predictions
During a recent episode of Mad Money, Jim Cramer discussed how the recent wave of deregulation by the U.S.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
10 Worst Performing Mid Cap Stocks to Buy According to Analysts
Market analysts are increasingly highlighting mid-cap stocks as a potentially attractive investment opportunity, particularly in the current economic climate.
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory
We came across a bullish thesis on Viking Therapeutics, Inc. (VKTX) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on VKTX.
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
15 Stocks That Took a Nosedive in January
Historically, the S&P 500's performance in January sets the pace for the rest of the year.
Jim Cramer’s Thoughts on These 7 Stocks
Jim Cramer, the host of Mad Money, recently revisited one of his core investment principles: "Nobody ever made a dime panicking." He emphasized that, no matter how many times ...
Jim Cramer’s Lightning Rounds: 9 Stocks in Focus
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock ...
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
11 Reddit Stocks with Biggest Upside Potential
Paul Hickey, Bespoke co-founder, together with Dana D'Auria, Envestnet co-chief Investment Officer, joined CNBC's 'Closing Bell: Overtime' on November 12 to discuss the market...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2024 Earnings Call Transcript October 23, 2024Viking Therapeutics, Inc. beats earnings expectations.
10 Best Hot Stocks To Buy Right Now
While the market is seeing significant positives after the Fed rate cut, there have been some pressures.
7 Best Performing Long Term Stocks in 2024
After the latest 50 basis point rate cut by the Federal Reserve, the market has been performing well.
10 Best Performing Small-Cap Stocks in 2024
The recent Fed rate cut has made the market cautiously optimistic. Despite the unusual timing, historical data suggests a continued upward trend.
10 Worst Booming Stocks to Buy According to Short Sellers
September has historically been one of the worst months for US stocks.
Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2
Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” second quarter 2024 investor letter.
Viking Therapeutics (VKTX) Fell Amid Rising Competition
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter.
Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
Viking Therapeutics (VKTX) Cooled Down After Strong Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2024 Earnings Call Transcript July 24, 2024Viking Therapeutics, Inc. beats earnings expectations.
10 Best Healthcare Stocks to Buy Under $50
This article looks at the 10 best healthcare stocks to buy under $50.
Here’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter.
Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
Baron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Viking Therapeutics (VKTX) Shares Rose in Q1
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded...
Jim Cramer Says You Should Not Buy These 11 Stocks
Jim Cramer in a latest program said the "bulls" want the economy to slow down, they want rate cuts as well as a strong demand so that "their companies" won't have to worry about...
Viking Therapeutics (VKTX) Stock Shot Up After the Release of a Study Report on Injectable Obesity Drug
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2024 investor letter.
This Biotech Stock is a “Strong Buy” According to Raymond James
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will look at a particular biotech which recently got a "Strong Buy" rating...
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc.
What Makes Viking Therapeutics (VKTX) an Attractive Potential Opportunity?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter.
10 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the ten best weight loss drug stocks to buy now.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
13 Best Booming Stocks to Buy Right Now
In this article, we will take a detailed look at the 13 Best Booming Stocks to Buy Right Now. For a quick overview of such stocks, read our article 5 Best Booming Stocks to...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
5 Best Weight Loss Stocks To Invest In
In this article, we will be taking a look at the 5 best weight loss stocks to invest in.
15 Best-Performing Stocks in the Last 12 Months
In this article, we will take a look at the 15 best-performing stocks in the last 12 months.
10 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 10 oversold biotech stocks to buy.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Stocks Wall Street Analysts and Billionaires Are Crazy About
In this piece, we will take a look at ten stocks that Wall Street analysts and billionaires are crazy about.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
